Alembic Limited

NSE ALEMBICLTD.NS

Alembic Limited EPS (Diluted) for the year ending March 31, 2024: USD 0.13

Alembic Limited EPS (Diluted) is USD 0.13 for the year ending March 31, 2024, a 38.91% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.
  • Alembic Limited EPS (Diluted) for the year ending March 31, 2023 was USD 0.09.
Key data
Date EPS (Diluted) Shares (Diluted, Weighted) Shares (Basic, Weighted) Revenue
Market news
Loading...
SV Wall Street
NSE: ALEMBICLTD.NS

Alembic Limited

CEO Ms. Malika Chirayu Amin
IPO Date July 1, 2002
Location India
Headquarters Alembic Road
Employees 285
Sector Utilities
Industries
Description

Alembic Limited engages in the manufacturing and marketing of fermentation and chemistry based active pharmaceuticals ingredients (API). It operates through API and Real Estate segments. The company is also involved in the construction of residential and commercial real estate projects; provision of project management and marketing consultancy services; and leasing of commercial properties. In addition, it operates co-generation plants with a total capacity of 11 MW; and wind power plants with a total capacity of 5 MW. The company also exports its products. Alembic Limited was founded in 1907 and is based in Vadodara, India. Alembic Limited is a subsidiary of Nirayu Limited.

Similar companies

CAPLIPOINT.NS

Caplin Point Laboratories Limited

USD 24.85

-1.27%

BLISSGVS.NS

Bliss GVS Pharma Limited

USD 1.75

-5.60%

AARTIDRUGS.NS

Aarti Drugs Limited

USD 4.84

1.76%

APLLTD.NS

Alembic Pharmaceuticals Limited

USD 10.21

0.43%

BALMLAWRIE.NS

Balmer Lawrie & Co. Ltd.

USD 2.21

0.76%

StockViz Staff

February 8, 2025

Any question? Send us an email